Overview Clinical Trial of Vormatrigine in Adult Patients With Epilepsy Status: ENROLLING_BY_INVITATION Trial end date: 2028-12-31 Target enrollment: Participant gender: Summary Open Label Extension Clinical Trial of Vormatrigine in Adult Patients with EpilepsyPhase: PHASE3 Details Lead Sponsor: Praxis Precision Medicines